Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites.

Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs JB, Britschgi TB, Latham JA, Schatzman RC, Pols HA, Brunkow ME.

Am J Hum Genet. 2004 Dec;75(6):1032-45. Epub 2004 Oct 26.

2.

A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.

Staehling-Hampton K, Proll S, Paeper BW, Zhao L, Charmley P, Brown A, Gardner JC, Galas D, Schatzman RC, Beighton P, Papapoulos S, Hamersma H, Brunkow ME.

Am J Med Genet. 2002 Jun 15;110(2):144-52.

PMID:
12116252
3.

Induction of p34cdc2 in mouse parotid glands upon activation of beta1-adrenergic receptors.

Waters CA, Morand JN, Schatzman RC, Carlson DM.

Cell Mol Biol (Noisy-le-grand). 1998 Mar;44(2):333-42.

PMID:
9593584
4.

Carmabins A and B, new lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.

Hooper GJ, Orjala J, Schatzman RC, Gerwick WH.

J Nat Prod. 1998 Apr;61(4):529-33.

PMID:
9584405
5.

HFE gene knockout produces mouse model of hereditary hemochromatosis.

Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O'Neill R, Britton RS, Bacon BR, Sly WS.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2492-7.

6.

The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.

Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1472-7.

7.

Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells.

Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS.

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12384-9.

8.

The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC.

J Biol Chem. 1997 May 30;272(22):14025-8.

9.

A 1.1-Mb transcript map of the hereditary hemochromatosis locus.

Ruddy DA, Kronmal GS, Lee VK, Mintier GA, Quintana L, Domingo R Jr, Meyer NC, Irrinki A, McClelland EE, Fullan A, Mapa FA, Moore T, Thomas W, Loeb DB, Harmon C, Tsuchihashi Z, Wolff RK, Schatzman RC, Feder JN.

Genome Res. 1997 May;7(5):441-56.

10.

Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2534-9.

11.

Alkaloids from the Tunicate Polycarpa aurata from Chuuk Atoll.

Abbas SA, Hossain MB, van Der Helm D, Schmitz FJ, Laney M, Cabuslay R, Schatzman RC.

J Org Chem. 1996 Dec 13;61(25):9072. No abstract available.

PMID:
11667906
12.

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK.

Nat Genet. 1996 Aug;13(4):399-408.

PMID:
8696333
13.

Alkaloids from the Tunicate Polycarpa aurata from Chuuk Atoll.

Abas SA, Hossain MB, van Der Helm D, Schmitz FJ, Laney M, Cabuslay R, Schatzman RC.

J Org Chem. 1996 Apr 19;61(8):2709-2712.

PMID:
11667102
14.

Suppression by mycophenolate mofetil of the neointimal thickening caused by vascular injury in a rat arterial stenosis model.

Fraser-Smith EB, Rosete JD, Schatzman RC.

J Pharmacol Exp Ther. 1995 Dec;275(3):1204-8.

PMID:
8531082
15.

Enzyme inhibitors: new and known polybrominated phenols and diphenyl ethers from four Indo-Pacific Dysidea sponges.

Fu X, Schmitz FJ, Govindan M, Abbas SA, Hanson KM, Horton PA, Crews P, Laney M, Schatzman RC.

J Nat Prod. 1995 Sep;58(9):1384-91. Erratum in: J Nat Prod 1996 Oct;59(10):1002. Schatzman C [corrected to Schatzman RC].

PMID:
7494145
16.

Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.

Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ.

Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6981-5.

17.

Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo.

Freitas VR, Fraser-Smith EB, Chiu S, Michelson S, Schatzman RC.

Antiviral Res. 1993 Aug;21(4):301-15.

PMID:
8215302
18.

Tyrosine phosphorylation of phospholipase C-gamma 2 upon cross-linking of membrane Ig on murine B lymphocytes.

Hempel WM, Schatzman RC, DeFranco AL.

J Immunol. 1992 May 15;148(10):3021-7.

PMID:
1578127
19.
20.

Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1.

Weiss A, Koretzky G, Schatzman RC, Kadlecek T.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5484-8.

21.

Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B.

Bruskin A, Jackson J, Bishop JM, McCarley DJ, Schatzman RC.

Oncogene. 1990 Jan;5(1):15-24.

PMID:
1969616
22.

Orientation of the v-erb-B gene product in the plasma membrane.

Schatzman RC, Evan GI, Privalsky ML, Bishop JM.

Mol Cell Biol. 1986 Apr;6(4):1329-33.

23.

Phospholipid-sensitive Ca2+-dependent protein kinase: a major protein phosphorylation system.

Kuo JF, Schatzman RC, Turner RS, Mazzei GJ.

Mol Cell Endocrinol. 1984 May;35(2-3):65-73. No abstract available.

PMID:
6203790
24.

Phospholipid-sensitive Ca2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist.

Mazzei GJ, Schatzman RC, Turner RS, Vogler WR, Kuo JF.

Biochem Pharmacol. 1984 Jan 1;33(1):125-30.

PMID:
6584106
25.
26.

Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases.

Qi DF, Schatzman RC, Mazzei GJ, Turner RS, Raynor RL, Liao S, Kuo JF.

Biochem J. 1983 Aug 1;213(2):281-8.

27.
28.
29.
30.
31.

Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents.

Wise BC, Glass DB, Chou CH, Raynor RL, Katoh N, Schatzman RC, Turner RS, Kibler RF, Kuo JF.

J Biol Chem. 1982 Jul 25;257(14):8489-95. No abstract available.

32.

Inhibition by melittin of phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases.

Katoh N, Raynor RL, Wise BC, Schatzman RC, Turner RS, Helfman DM, Fain JN, Kuo JF.

Biochem J. 1982 Jan 15;202(1):217-24.

33.

Inhibition by phenothiazine antipsychotic drugs of calcium-dependent phosphorylation of cerebral cortex proteins regulated by phospholipid or calmodulin.

Wrenn RW, Katoh N, Schatzman RC, Kuo JF.

Life Sci. 1981 Aug 17;29(7):725-33. No abstract available.

PMID:
7278508
34.

Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs.

Schatzman RC, Wise BC, Kuo JF.

Biochem Biophys Res Commun. 1981 Feb 12;98(3):669-76. No abstract available.

PMID:
6112002

Supplemental Content

Loading ...
Support Center